Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Sep 15;366(Pt 3):831–837. doi: 10.1042/BJ20020279

The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.

Amy J Johnson 1, Ao-Lin Hsu 1, Ho-Pi Lin 1, Xueqin Song 1, Ching-Shih Chen 1
PMCID: PMC1222837  PMID: 12076251

Abstract

Substantial evidence indicates that the cyclo-oxygenase-2 (COX-2) inhibitor celecoxib, a widely prescribed anti-inflammatory agent, displays anti-tumour effect by sensitizing cancer cells to apoptosis. As part of our effort to understand the mechanism by which celecoxib mediates apoptosis in androgen-independent prostate cancer cells, we investigated its effect on intracellular calcium concentration ([Ca(2+)](i)). Digital ratiometric imaging analysis indicates that exposure of PC-3 cells to celecoxib stimulates an immediate [Ca(2+)](i) rise in a dose- and time-dependent manner. Kinetic data show that this Ca(2+) signal arises from internal Ca(2+) release in conjunction with external Ca(2+) influx. Examinations of the biochemical mechanism responsible for this Ca(2+) mobilization indicate that celecoxib blocks endoplasmic reticulum (ER) Ca(2+)-ATPases. Consequently, inhibition of this Ca(2+) reuptake mechanism results in Ca(2+) mobilization from ER stores followed by capacitative calcium entry, leading to [Ca(2+)](i) elevation. In view of the important role of Ca(2+) in apoptosis regulation, this Ca(2+) perturbation may represent part of the signalling mechanism that celecoxib uses to trigger rapid apoptotic death in cancer cells. This Ca(2+)-ATPase inhibitory activity is highly specific for celecoxib, and is not noted with other COX inhibitors tested, including aspirin, ibuprofen, naproxen, rofecoxib (Vioxx), DuP697 and NS398. Moreover, it is noteworthy that this activity is also observed in many other cell lines examined, including A7r5 smooth muscle cells, NIH 3T3 fibroblast cells and Jurkat T cells. Consequently, this Ca(2+)-perturbing effect may provide a plausible link with the reported toxicities of celecoxib such as increased cardiovascular risks in long-term anti-inflammatory therapy.

Full Text

The Full Text of this article is available as a PDF (216.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asai A., Qiu J. h., Narita Y., Chi S., Saito N., Shinoura N., Hamada H., Kuchino Y., Kirino T. High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem. 1999 Nov 26;274(48):34450–34458. doi: 10.1074/jbc.274.48.34450. [DOI] [PubMed] [Google Scholar]
  2. Berridge M. J., Bootman M. D., Lipp P. Calcium--a life and death signal. Nature. 1998 Oct 15;395(6703):645–648. doi: 10.1038/27094. [DOI] [PubMed] [Google Scholar]
  3. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 1993 Jan 28;361(6410):315–325. doi: 10.1038/361315a0. [DOI] [PubMed] [Google Scholar]
  4. Bilmen J. G., Khan S. Z., Javed M. H., Michelangeli F. Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem. 2001 Dec;268(23):6318–6327. doi: 10.1046/j.0014-2956.2001.02589.x. [DOI] [PubMed] [Google Scholar]
  5. Chamberlain B. K., Volpe P., Fleischer S. Inhibition of calcium-induced calcium release from purified cardiac sarcoplasmic reticulum vesicles. J Biol Chem. 1984 Jun 25;259(12):7547–7553. [PubMed] [Google Scholar]
  6. Chan T. A., Morin P. J., Vogelstein B., Kinzler K. W. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):681–686. doi: 10.1073/pnas.95.2.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cheng Yan, Austin Sandra C., Rocca Bianca, Koller Beverly H., Coffman Thomas M., Grosser Tilo, Lawson John A., FitzGerald Garret A. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002 Apr 19;296(5567):539–541. doi: 10.1126/science.1068711. [DOI] [PubMed] [Google Scholar]
  8. Cobbold P. H., Rink T. J. Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem J. 1987 Dec 1;248(2):313–328. doi: 10.1042/bj2480313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davies N. M., McLachlan A. J., Day R. O., Williams K. M. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet. 2000 Mar;38(3):225–242. doi: 10.2165/00003088-200038030-00003. [DOI] [PubMed] [Google Scholar]
  10. DeWitt D. L. Cox-2-selective inhibitors: the new super aspirins. Mol Pharmacol. 1999 Apr;55(4):625–631. [PubMed] [Google Scholar]
  11. Dempke W., Rie C., Grothey A., Schmoll H. J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol. 2001 Jul;127(7):411–417. doi: 10.1007/s004320000225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dubois R. N., Abramson S. B., Crofford L., Gupta R. A., Simon L. S., Van De Putte L. B., Lipsky P. E. Cyclooxygenase in biology and disease. FASEB J. 1998 Sep;12(12):1063–1073. [PubMed] [Google Scholar]
  13. Dyer J. L., Khan S. Zafar, Bilmen J. G., Hawtin S. R., Wheatley M., Javed M-ul-H, Michelangeli F. Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium. 2002 Jan;31(1):45–52. doi: 10.1054/ceca.2001.0259. [DOI] [PubMed] [Google Scholar]
  14. Everts B., Währborg P., Hedner T. COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs. Clin Rheumatol. 2000;19(5):331–343. doi: 10.1007/s100670070024. [DOI] [PubMed] [Google Scholar]
  15. Fowler C. J., Tiger G. Calibration of Fura-2 signals introduces errors into measurement of thrombin-stimulated calcium mobilisation in human platelets. Clin Chim Acta. 1997 Sep 30;265(2):247–261. doi: 10.1016/s0009-8981(97)00139-3. [DOI] [PubMed] [Google Scholar]
  16. Furuya Y., Lundmo P., Short A. D., Gill D. L., Isaacs J. T. The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res. 1994 Dec 1;54(23):6167–6175. [PubMed] [Google Scholar]
  17. Goel A., Boland C. R., Chauhan D. P. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 2001 Oct 30;172(2):111–118. doi: 10.1016/s0304-3835(01)00655-3. [DOI] [PubMed] [Google Scholar]
  18. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  19. Hanif R., Pittas A., Feng Y., Koutsos M. I., Qiao L., Staiano-Coico L., Shiff S. I., Rigas B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol. 1996 Jul 26;52(2):237–245. doi: 10.1016/0006-2952(96)00181-5. [DOI] [PubMed] [Google Scholar]
  20. Hawkey C. J. COX-2 inhibitors. Lancet. 1999 Jan 23;353(9149):307–314. doi: 10.1016/s0140-6736(98)12154-2. [DOI] [PubMed] [Google Scholar]
  21. Hill T. D., Berggren P. O., Boynton A. L. Heparin inhibits inositol trisphosphate-induced calcium release from permeabilized rat liver cells. Biochem Biophys Res Commun. 1987 Dec 31;149(3):897–901. doi: 10.1016/0006-291x(87)90492-x. [DOI] [PubMed] [Google Scholar]
  22. Hla T., Bishop-Bailey D., Liu C. H., Schaefers H. J., Trifan O. C. Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol. 1999 May;31(5):551–557. doi: 10.1016/s1357-2725(98)00152-6. [DOI] [PubMed] [Google Scholar]
  23. Hla T., Ristimäki A., Appleby S., Barriocanal J. G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci. 1993 Nov 30;696:197–204. doi: 10.1111/j.1749-6632.1993.tb17152.x. [DOI] [PubMed] [Google Scholar]
  24. Hsu A. L., Ching T. T., Wang D. S., Song X., Rangnekar V. M., Chen C. S. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem. 2000 Apr 14;275(15):11397–11403. doi: 10.1074/jbc.275.15.11397. [DOI] [PubMed] [Google Scholar]
  25. Johnson A. J., song X., Hsu A., Chen C. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells. Adv Enzyme Regul. 2001;41:221–235. doi: 10.1016/s0065-2571(00)00015-7. [DOI] [PubMed] [Google Scholar]
  26. Jones M. K., Wang H., Peskar B. M., Levin E., Itani R. M., Sarfeh I. J., Tarnawski A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med. 1999 Dec;5(12):1418–1423. doi: 10.1038/70995. [DOI] [PubMed] [Google Scholar]
  27. Kelloff G. J., Boone C. W., Crowell J. A., Steele V. E., Lubet R. A., Doody L. A., Malone W. F., Hawk E. T., Sigman C. C. New agents for cancer chemoprevention. J Cell Biochem Suppl. 1996;26:1–28. doi: 10.1002/jcb.240630703. [DOI] [PubMed] [Google Scholar]
  28. Lehotsky J., Raeymaekers L., Missiaen L., Wuytack F., De Smedt H., Casteels R. Stimulation of the catalytic cycle of the Ca2+ pump of porcine plasma-membranes by negatively charged phospholipids. Biochim Biophys Acta. 1992 Mar 23;1105(1):118–124. doi: 10.1016/0005-2736(92)90169-m. [DOI] [PubMed] [Google Scholar]
  29. Liu X. H., Yao S., Kirschenbaum A., Levine A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res. 1998 Oct 1;58(19):4245–4249. [PubMed] [Google Scholar]
  30. Logan-Smith M. J., Lockyer P. J., East J. M., Lee A. G. Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+. J Biol Chem. 2001 Oct 9;276(50):46905–46911. doi: 10.1074/jbc.M108778200. [DOI] [PubMed] [Google Scholar]
  31. Lu P. J., Gou D. M., Shieh W. R., Chen C. S. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site. Biochemistry. 1994 Sep 27;33(38):11586–11597. doi: 10.1021/bi00204a021. [DOI] [PubMed] [Google Scholar]
  32. Martikainen P., Kyprianou N., Tucker R. W., Isaacs J. T. Programmed death of nonproliferating androgen-independent prostatic cancer cells. Cancer Res. 1991 Sep 1;51(17):4693–4700. [PubMed] [Google Scholar]
  33. Marx J. Cancer research. Anti-inflammatories inhibit cancer growth--but how? Science. 2001 Jan 26;291(5504):581–582. doi: 10.1126/science.291.5504.581. [DOI] [PubMed] [Google Scholar]
  34. McConkey D. J., Nicotera P., Hartzell P., Bellomo G., Wyllie A. H., Orrenius S. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys. 1989 Feb 15;269(1):365–370. doi: 10.1016/0003-9861(89)90119-7. [DOI] [PubMed] [Google Scholar]
  35. McConnell E. J., Wagoner M. J., Keenan C. E., Raess B. U. Inhibition of calmodulin-stimulated (Ca2+ + Mg2+)-ATPase activity by dimethyl sulfoxide. Biochem Pharmacol. 1999 Jan 1;57(1):39–44. doi: 10.1016/s0006-2952(98)00259-7. [DOI] [PubMed] [Google Scholar]
  36. Molinari M., Carafoli E. Calpain: a cytosolic proteinase active at the membranes. J Membr Biol. 1997 Mar 1;156(1):1–8. doi: 10.1007/s002329900181. [DOI] [PubMed] [Google Scholar]
  37. Mukherjee D., Nissen S. E., Topol E. J. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001 Aug 22;286(8):954–959. doi: 10.1001/jama.286.8.954. [DOI] [PubMed] [Google Scholar]
  38. Muscará M. N., Vergnolle N., Lovren F., Triggle C. R., Elliott S. N., Asfaha S., Wallace J. L. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol. 2000 Apr;129(7):1423–1430. doi: 10.1038/sj.bjp.0703232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Neamati N., Fernandez A., Wright S., Kiefer J., McConkey D. J. Degradation of lamin B1 precedes oligonucleosomal DNA fragmentation in apoptotic thymocytes and isolated thymocyte nuclei. J Immunol. 1995 Apr 15;154(8):3788–3795. [PubMed] [Google Scholar]
  40. Pacher P., Hajnóczky G. Propagation of the apoptotic signal by mitochondrial waves. EMBO J. 2001 Aug 1;20(15):4107–4121. doi: 10.1093/emboj/20.15.4107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Piazza G. A., Rahm A. L., Krutzsch M., Sperl G., Paranka N. S., Gross P. H., Brendel K., Burt R. W., Alberts D. S., Pamukcu R. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 1995 Jul 15;55(14):3110–3116. [PubMed] [Google Scholar]
  42. Poenie M., Tsien R. Y., Schmitt-Verhulst A. M. Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets. EMBO J. 1987 Aug;6(8):2223–2232. doi: 10.1002/j.1460-2075.1987.tb02494.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pozzan T., Rizzuto R., Volpe P., Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol Rev. 1994 Jul;74(3):595–636. doi: 10.1152/physrev.1994.74.3.595. [DOI] [PubMed] [Google Scholar]
  44. Prescott S. M., Fitzpatrick F. A. Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta. 2000 Mar 27;1470(2):M69–M78. doi: 10.1016/s0304-419x(00)00006-8. [DOI] [PubMed] [Google Scholar]
  45. Putney J. W., Jr A model for receptor-regulated calcium entry. Cell Calcium. 1986 Feb;7(1):1–12. doi: 10.1016/0143-4160(86)90026-6. [DOI] [PubMed] [Google Scholar]
  46. Sheng H., Shao J., Morrow J. D., Beauchamp R. D., DuBois R. N. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998 Jan 15;58(2):362–366. [PubMed] [Google Scholar]
  47. Song Xueqin, Lin Ho-Pi, Johnson Amy J., Tseng Ping-Hui, Yang Ya-Ting, Kulp Samuel K., Chen Ching-Shih. Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells. J Natl Cancer Inst. 2002 Apr 17;94(8):585–591. doi: 10.1093/jnci/94.8.585. [DOI] [PubMed] [Google Scholar]
  48. Taketo M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst. 1998 Oct 21;90(20):1529–1536. doi: 10.1093/jnci/90.20.1529. [DOI] [PubMed] [Google Scholar]
  49. Tegeder I., Pfeilschifter J., Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001 Oct;15(12):2057–2072. doi: 10.1096/fj.01-0390rev. [DOI] [PubMed] [Google Scholar]
  50. Thastrup O., Cullen P. J., Drøbak B. K., Hanley M. R., Dawson A. P. Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2466–2470. doi: 10.1073/pnas.87.7.2466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Thompson H. J., Jiang C., Lu J., Mehta R. G., Piazza G. A., Paranka N. S., Pamukcu R., Ahnen D. J. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer Res. 1997 Jan 15;57(2):267–271. [PubMed] [Google Scholar]
  52. Tiffert T., Lew V. L. Kinetics of inhibition of the plasma membrane calcium pump by vanadate in intact human red cells. Cell Calcium. 2001 Nov;30(5):337–342. doi: 10.1054/ceca.2001.0241. [DOI] [PubMed] [Google Scholar]
  53. Tombal B., Weeraratna A. T., Denmeade S. R., Isaacs J. T. Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells. Prostate. 2000 Jun 1;43(4):303–317. doi: 10.1002/1097-0045(20000601)43:4<303::aid-pros10>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  54. Wertz I. E., Dixit V. M. Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. J Biol Chem. 2000 Apr 14;275(15):11470–11477. doi: 10.1074/jbc.275.15.11470. [DOI] [PubMed] [Google Scholar]
  55. Williams C. S., Tsujii M., Reese J., Dey S. K., DuBois R. N. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest. 2000 Jun;105(11):1589–1594. doi: 10.1172/JCI9621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Worley P. F., Baraban J. M., Colvin J. S., Snyder S. H. Inositol trisphosphate receptor localization in brain: variable stoichiometry with protein kinase C. Nature. 1987 Jan 8;325(7000):159–161. doi: 10.1038/325159a0. [DOI] [PubMed] [Google Scholar]
  57. Yakovlev A. G., Wang G., Stoica B. A., Boulares H. A., Spoonde A. Y., Yoshihara K., Smulson M. E. A role of the Ca2+/Mg2+-dependent endonuclease in apoptosis and its inhibition by Poly(ADP-ribose) polymerase. J Biol Chem. 2000 Jul 14;275(28):21302–21308. doi: 10.1074/jbc.M001087200. [DOI] [PubMed] [Google Scholar]
  58. Zhang X., Morham S. G., Langenbach R., Young D. A. Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med. 1999 Aug 16;190(4):451–459. doi: 10.1084/jem.190.4.451. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES